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Introduction
Rectal carcinoma is an invasive cancer with high incidence 
rates.1 While surgical resection is standard treatment, local 
recurrence often occurs.2 As a result, the implementation of 
presurgical chemoradiation treatment (CRT) is the gold stan-
dard in the treatment of rectal cancer. This strategy enhances 
local disease control, reduces metastases, and increases sur-
vival.3 However, CRT has been associated with significant 
adverse effects. It is well acknowledged that patients 
undergoing chemotherapy and radiation therapy experience 
an array of treatment-related side effects, with declines in 
cardiovascular and muscular function, functional capacity, 
and increased fatigue.4-7
Physical exercise is an important treatment modality in 
the management of physical health and symptoms in cancer 
patients and survivors.8 Exercise interventions during either 
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Abstract
Background: Neoadjuvant chemoradiation treatment (CRT) in rectal cancer patients is associated with a reduction 
in physical capacity, lean mass and increased fatigue. As a countermeasure to these treatment-related adverse effects, 
we examined the feasibility and preliminary efficacy of a 10-week exercise program during CRT. Methods: Ten rectal 
cancer patients (7 men, aged 27-70 years, body mass index = 26.4 ± 3.8 kg/m2) receiving CRT undertook supervised 
resistance and aerobic exercise twice weekly. Assessments were undertaken pre- and post-intervention for upper 
and lower body muscle strength by 1-RM, muscle endurance, physical performance tests, body composition by dual 
X-ray absorptiometry, quality of life, and fatigue. Results: There was a significant loss in appendicular skeletal muscle 
(−1.1 kg, P = .012), and fat mass (−0.8 kg, P = .029) following CRT. Despite the loss in skeletal muscle, leg press (P = 
.030) and leg extension (P = .046) strength improved by 27.2% and 22.7%, respectively, and leg press endurance by 76.7% 
(P = .007). Changes in strength were accompanied by improved performance (P < .05) in 6-m fast walking speed (6.9%) 
and dynamic balance as determined by the 6-m backwards walk (15.5%). There was minimal change in quality of life and 
fatigue, and no adverse events related to training. Conclusions: Exercise during neoadjuvant CRT appears to be feasible 
and well tolerated in rectal cancer patients and may enhance physical function while minimizing adverse changes in body 
composition and cancer-related fatigue. These initial findings need to be confirmed in randomized controlled trials.
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chemotherapy4 or radiation therapy5 have resulted in numer-
ous positive physiological and psychological benefits in 
cancer survivors. Although these results provide support for 
the role of exercise in the reduction of several treatment-
related adverse effects of each therapy individually, it is yet 
to be determined how a comprehensive exercise program 
would affect patients undergoing combined therapy, such as 
intensive neoadjuvant CRT.
Current exercise recommendations include the undertak-
ing of aerobic and resistance exercise to enhance the cardio-
vascular and musculoskeletal function of cancer 
survivors.9,10 However, the potential role of exercise in 
improving physical performance together with body com-
position and quality of life (QOL) during intensive neoadju-
vant CRT for rectal cancer has not been investigated. Cancer 
patients, despite the challenges of cancer diagnosis, can be 
highly motivated to make behavioral improvements. This 
“teachable moment” may be an ideal time to introduce an 
exercise program and encourage positive behavior change.11
In this study, we examined if a supervised aerobic and 
resistance exercise program implemented during neoadju-
vant CRT was feasible and produced any beneficial effects 
in rectal cancer patients. Specifically, we aimed to deter-
mine the feasibility and preliminary efficacy of a 10-week 
exercise intervention program on muscle strength and 
endurance, physical performance, body composition, can-
cer-specific QOL, and fatigue.
Methods
Patient Recruitment
Fifteen localized rectal cancer patients scheduled for neoadju-
vant chemoradiation prior to rectal resection were referred by 
their radiation oncologist. Eligibility criteria included patients 
scheduled for surgery for localized rectal cancer; absence of 
any acute illness or any musculoskeletal, cardiovascular, or 
neurological disorder that could inhibit the ability to walk 
400-m unassisted and undertake upper and lower body exer-
cise; and obtained medical clearance from their general prac-
titioner. All patients provided written informed consent. The 
study was approved by the university ethics committee.
Exercise Intervention
The exercise program was conducted at 2 university-affiliated 
exercise clinics located in metropolitan Perth and consisted of 
twice weekly 1-hour supervised sessions by an accredited 
exercise physiologist for a period of 10 weeks during CRT. 
Radiation treatment was undertaken prior to the exercise ses-
sion, while chemotherapy was administered via a portable 
chemo pump during radiation treatment and exercise. Patients 
were also required to complete additional aerobic exercise (at 
least 2 × 15 minutes or more sessions per week), in order to 
meet the exercise guideline of 150 minutes per week,10 and 
this was monitored weekly throughout the exercise interven-
tion. Each session commenced with a 5-minute warmup fol-
lowed by progressive resistance training targeting the major 
upper and lower body muscle groups.12 Exercises performed 
were the chest press, seated row, lat pull down, leg press, leg 
extension, and leg curl. Patients performed 2 to 4 sets per 
exercise at a 6 to 12 repetition maximum (RM) intensity in a 
periodized fashion where the number of sets and repetitions 
were altered.13 The exercises were performed using standard 
resistance training machine equipment. Aerobic exercise was 
undertaken for 20 minutes at an intensity of 60% to 80% of 
estimated maximum heart rate and included activities such as 
walking or jogging on a treadmill and cycling or rowing on a 
stationary ergometer. The session concluded with a 5-minute 
cooldown period.
Feasibility
Feasibility was assessed by determining recruitment and 
completion rates, overall program adherence, which con-
sisted of a number of completed and missed sessions, and 
program compliance determined by the prescribed versus 
actual exercise completed.
Muscle Strength and Endurance
Dynamic muscle strength for the chest press, seated row, 
leg press, and leg extension was assessed using the 1-RM 
method, which is the maximal weight that can be lifted one 
time.14 To evaluate upper and lower body muscle endur-
ance, the maximal number of repetitions performed at 70% 
of the pre-exercise 1-RM for the chest press and the leg 
press were used.15,16
Physical Performance
A battery of tests that included the usual and fast 6-m walk, 
6-m backwards walk (as a measure of dynamic balance), 
repeated chair rise (lower body muscle function incorporat-
ing muscle power, strength, and endurance), stair climb, 
and the 400-m walk (as a measure of cardiorespiratory 
endurance and walking endurance) were used to assess 
physical performance.17 All tests were performed in tripli-
cate, except for the 400-m walk. For the 400-m walk, heart 
rate recovery was recorded immediately after exercise, at 1 
minute, and at 2 minutes via a heart rate monitor (Model 
S610i; Polar Electro Oy, Kempele, Finland).
Body Composition
Total body lean mass (LM), fat mass, and percentage fat 
were assessed by dual-energy X-ray absorptiometry (DXA, 
Hologic Discovery A, Waltham, MA). In addition, regional 
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composition was determined by manipulation of the seg-
mental lines according to specific anatomical landmarks.18 
Appendicular skeletal muscle (ASM) was derived using the 
sum of both the upper and lower limb LM.19
Quality of Life and Fatigue
The European Organization for Research and Treatment of 
Cancer Quality of Life Questionnaire-Core 30 (EORTC 
QLQ-C30) version 3.0 was used to assess changes in levels 
of health-related QOL, with higher scores indicating better 
global health and functioning while lower scores for the 
symptom subcategories, such as pain and fatigue, indicate a 
reduction in symptoms.20 Fatigue was measured with the 
validated 30-item short form of the Multidimensional Fatigue 
Symptom Inventory (MFSI-SF), with a higher subcategory 
score and total score representing greater fatigue except for 
vigor where a higher score represents enhanced vigor.21
Other Measures
Height and body weight were measured using a stadiometer 
and electronic scales, respectively, with body mass index 
(kg/m2) calculated. Self-reported physical activity was 
assessed with the Leisure Score Index of the Godin Leisure-
Time Exercise Questionnaire.22
Statistical Analysis
All statistical analyses were performed using a statistical 
software program (PASW v 19 for Windows, SPSS, Inc, 
Chicago, IL). Normality of the data was assessed using the 
Shapiro-Wilk test. Analyses included standard descriptive 
statistics and paired t tests or the Wilcoxon signed -rank 
test, as appropriate, to compare changes in the variables at 
pre-exercise and post-exercise time points. For consistency, 
all results are reported as the change in mean values and the 
95% confidence intervals (95% CIs). Intention-to-treat was 
utilized for all analyses using maximum likelihood imputa-
tion of missing values (expectation maximization). Effect 
sizes (ES) were calculated as ES = (Mean
Post
 − Mean
Pre
/
SD
Pre
) and defined as small (d  =  .2), medium (d   =  .5), and 
large effect (d ⩾ .8).23 All tests were 2-tailed with an α level 
of P ⩽ .05 set as the criterion for statistical significance.
Results
Patient Characteristics and Study Feasibility 
Outcomes
Of the 15 patients, 5 patients declined to participate, citing 
long travelling distance, no available transport to the testing 
site, and wanting to focus on medical treatment only, result-
ing in 10 patients enrolling in the study and a recruitment 
rate of 67%. Two patients completed the training sessions 
but did not complete the post-intervention assessments, 
reporting feeling unwell, and 1 patient withdrew after week 
4, although this was unrelated to the exercise intervention. 
The remaining patients completed training and both assess-
ment time points for a completion rate of 70%. Patient pre-
exercise characteristics are presented in Table 1. Baseline 
data for 6 patients have also been reported elsewhere as part 
of a report focusing on presurgical exercise and follow-up 
after surgery.24 The mean age of patients was 54.6 ± 14.1 
years with a body mass index of 26.4 ± 3.8 kg/m2. Five 
patients completed 17 sessions or more out of the possible 
20 sessions (85% of scheduled sessions), and overall atten-
dance for the 10 participants was 77%. Patients reported 
feeling unwell as the main reason for not attending the exer-
cise training sessions. Sessions were individualized by the 
exercise physiologist based on clinical requirements and/or 
short-term treatment-related adverse effects, such as irrita-
tion secondary to radiotherapy, with the resulting program 
compliance being 100%. Physical activity as determined by 
the Godin Leisure Score Index increased from 16.7 to 25.6, 
which approached significance (P = .088) and was due to an 
increase in the frequency of strenuous activity resulting 
from the intervention. There were no adverse events as a 
result of the exercise program.
Muscle Strength and Endurance
Muscle strength significantly improved for the lower 
limb exercises, the leg press (P = .030) and leg extension 
Table 1. Baseline Physical Characteristics of Rectal Cancer 
Patients Undergoing Chemoradiation Therapy (n = 10).
Variables Mean ± SD n %
Age (years) 54.6 ± 14.1  
Males 7 70
Height (cm) 171.3 ± 6.6  
Weight (kg) 77.8 ± 14.1  
BMI (kg/m2) 26.4 ± 3.8  
Married 6 60
Number of medications 1.3 ± 2.5  
Number of comorbiditiesa 0.7 ± 1.1  
Godin LSIb 16.7 ± 12.8  
Mini Nutritional Assessment 25.3 ± 2.7  
Smoking
 Past 3 30
 Never 6 60
Alcohol intake
 Yes 10 100
Abbreviations: BMI, body mass index; LSI, Leisure Score Index.
aCardiovascular, hypertension, and hyperlipidemia.
bLSI with a moderate-to-strenuous LSI ⩾24 classed as active and ⩽23 
classed as insufficiently active.
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(P = .046) by 27.2% and 22.7%, respectively (Table 2). 
There was no significant change in chest press muscle 
endurance, however, leg press endurance improved by 
76.7% (P = .007).
Physical Performance
Following the 10-week training period, there was a sig-
nificant improvement (P < .05) in the 6-m fast walk 
(6.9%) and 6-m backwards walk (15.5%; Table 2), with 
moderate to large effect sizes (ES > .6). In addition, 
improved performance in the repeated chair rise test of 
10.6% approached significance (P = .053). Although 
there was no significant change in the 400-m walk time, 
there was a significant reduction (P = .006) in heart rate 
of 10 beats per minute immediately after the completion 
of the test indicating potential improvement in heart rate 
recovery.
Body Composition
There was a significant loss in ASM (−1.1 kg, 95% CI = 
−1.9 to −0.3, P = .012), which was predominantly a 
result of a decline in lower limb LM (−0.9 kg, 95% CI = 
−1.5 to −0.3, P = .007; Table 3). Total body fat mass was 
also significantly reduced (P = .029) following CRT by 
−0.8 kg (95% CI = −1.6 to −0.1) and was largely due to 
a reduction in trunk fat (−0.7 kg, 95% CI = −1.3 to 0.0, 
P = .046).
Quality of Life and Fatigue
There were significant changes (P < .05) in 3 of the measures 
of QOL (Table 4)—emotional function, diarrhea, and financial 
difficulties, with patients also reporting a trend for less consti-
pation (P = .078) with a moderate effect size (ES = .65). In 
addition, based on the MFSI-SF, patients overall tended to 
report higher levels of fatigue at post-exercise (Table 4), with a 
significant change (P = .048) in the Mental Scale subcategory.
Discussion
We examined the feasibility and preliminary efficacy of a 
combined resistance and aerobic exercise program in rectal 
cancer patients undergoing neoadjuvant chemoradiation, a 
period of time inherently stressful to the patient with an 
array of treatment-related adverse effects. There were 3 
important findings: (1) exercise was feasible during this 
time period and appeared to be well-tolerated with no 
adverse events; (2) improvements were observed for lower 
body muscle strength and endurance, and also physical 
function; and (3) despite undergoing CRT, there were no 
substantial adverse changes in fatigue or quality of life.
Two to 3 weeks following a diagnosis of rectal cancer, 
patients scheduled for rectal resection with curative intent 
undergo at least 6 to 8 weeks of CRT and are then observed 
for approximately 7 to 8 weeks before surgery. Typically, 
exercise would not be prescribed or undertaken during this 
period; however, an expanding role for exercise medicine in 
Table 2. Effect on Physical Performance, Muscular Strength, and Endurance Measures in Rectal Cancer Patients Undergoing CRT 
(Mean ± SD; n = 10).
Variables Pre-exercise Post-exercise
Mean Difference [95%CI]
Pre to Post P ES
Muscular strength (kg)
 Chest press 36.0 ± 16.8 38.4 ± 19.6 2.4 [−1.6 to 6.4] .214 0.14
 Seated row 67.0 ± 23.2 67.8 ± 25.1 0.8 [−3.1 to 4.8] .656 0.04
 Leg press 121.0 ± 48.4 153.9 ± 65.8 32.9 [3.9 to 61.9] .030* 0.68
 Leg extension 56.0 ± 22.5 68.7 ± 31.4 12.7 [0.3 to 25.1] .046#,* 0.56
Muscular endurance (rep)
 Chest press 10.9 ± 3.4 12.8 ± 5.5 1.9 [−3.1 to 7.0] .358# 0.56
 Leg press 12.0 ± 7.1 21.2 ± 11.2 9.2 [3.2 to 15.3] .007* 1.30
Physical performance (s)
 6-m usual walk 4.2 ± 0.4 3.9 ± 0.5 −0.3 [−0.7 to 0.1] .167 0.75
 6-m fast walk 2.9 ± 0.3 2.7 ± 0.4 −0.2 [−0.3 to 0.0] .047#,* 0.67
 6-m backwards walk 14.2 ± 3.5 12.0 ± 2.8 −2.2 [−3.8 to 0.6] .012* 0.63
 400-m walk 237.2 ± 22.5 229.7 ± 28.2 −7.6 [−24.8 to 9.7] .347 0.34
 Chair rise 10.4 ± 1.1 9.3 ± 1.5 −1.2 [−2.3 to 0.0] .053 1.09
 Stair climb 4.6 ± 0.9 4.4 ± 1.0 −0.2 [−0.6 to 0.2] .283 0.22
Abbreviations: CRT, chemoradiation treatment; CI, confidence interval; ES, effect size; rep, repetitions performed at 70% of 1-repetition maximum 
(1-RM).
*Significant (P ⩽ .05).
#Wilcoxon signed ranked test.
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cancer management prior to surgery has rapidly developed 
over the past 3 years.12,24-26 In our study, exercise appeared 
to be feasible, based on recruitment (67%) and completion 
rates (70%), and an overall exercise session attendance of 
77%. It is noteworthy that only 2 patients missed an exer-
cise training session due to treatment-related illness and 
Table 3. Total and Regional Body Composition in Rectal Cancer Patients Undergoing CRT (Mean ± SD; n = 10).
Variables Pre-exercise Post-exercise
Mean Difference [95%CI]
Pre to Post P ES
Lean mass (kg)
 Total body 55.7 ± 10.6 54.7 ± 10.5 −1.0 [−2.6 to 0.6] .190 0.09
 Upper limb 6.3 ± 1.7 6.1 ± 1.8 −0.2 [−0.5 to 0.1] .142 0.12
 Lower limb 17.4 ± 3.3 16.4 ± 3.9 −0.9 [−1.5 to −0.3] .007* 0.27
 ASM 23.7 ± 4.9 22.6 ± 5.6 −1.1 [−1.9 to −0.3] .012* 0.23
Fat mass (kg)
 Total body 20.0 ± 7.5 19.2 ± 6.9 −0.8 [−1.6 to −0.1] .029* 0.11
 Upper limb 2.3 ± 0.8 2.3 ± 0.9 0.0 [−0.1 to 0.2] .710 0.00
 Lower limb 6.8 ± 2.4 6.6 ± 2.4 −0.2 [−0.6 to 0.2] .318 0.08
 Trunk 9.9 ± 5.0 9.2 ± 4.2 −0.7 [−1.3 to 0.0] .046* 0.14
 Body fat (%) 25.3 ± 7.7 25.0 ± 7.7 −0.3 [−0.8 to 0.2] .214 0.04
Abbreviations: CRT, chemoradiation treatment; CI, confidence interval; ES, effect size; ASM, appendicular skeletal muscle.
*Significant (P ⩽ .05).
Table 4. Quality of Life and Fatigue in Rectal Cancer Patients Undergoing CRT (Mean ± SD; n = 10).
Measures Pre-exercise Post-exercise
Mean Difference [95%CI]
Pre to Post P ES
EORTC QLQ-C30 subcategories
 Global Health 61.7 ± 15.3 65.0 ± 11.9 3.3 [−4.1 to 10.7] .335 0.22
 Physical Functioning 95.3 ± 7.1 93.1 ± 8.3 −2.3 [−11.2 to 6.7] .528# 0.32
 Role Functioning 78.3 ± 27.3 75.8 ± 21.5 −2.6 [−22.5 to 17.4] .799# 0.10
 Emotional Functioning 75.0 ± 14.2 84.9 ± 26.4 9.9 [0.1 to 19.7] .048* 0.70
 Cognitive Functioning 78.3 ± 17.7 75.7 ± 20.5 −2.6 [−9.3 to 4.1] .405 0.15
 Social Functioning 73.3 ± 23.8 73.7 ± 19.7 0.4 [−16.9 to 17.6] .964 0.02
 Fatigue 25.6 ± 18.2 21.6 ± 15.4 −4.0 [−19.0 to 11.0] .563 0.22
 Nausea and Vomiting 5.0 ± 15.8 4.8 ± 6.6 −0.2 [−12.5 to 12.0] .496# 0.01
 Pain 13.3 ± 13.2 10.0 ± 20.8 −3.3 [−19.1 to 12.5] .310# 0.25
 Dyspnea 6.7 ± 14.1 0.0 −6.7 [−16.7 to 3.4] .157# 0.48
 Insomnia 23.3 ± 16.1 28.0 ± 21.7 4.7 [−2.8 to 12.1] .141# 0.29
 Appetite Loss 20.0 ± 28.1 26.2 ± 24.7 6.2 [−12.1 to 24.4] .684# 0.22
 Constipation 20.0 ± 23.3 4.9 ± 10.3 −15.1 [−31.5 to 1.3] .078# 0.65
 Diarrhea 36.7 ± 29.2 21.6 ± 25.7 −15.1 [−26.1 to −4.2] .027#* 0.52
 Financial Difficulties 33.3 ± 27.2 23.8 ± 30.2 −9.5 [−19.0 to 0.0] .038#,* 0.35
MFSI-SF subcategories
 General Scale 6.8 ± 5.0 8.1 ± 6.0 1.3 [−3.9 to 6.5] .587 0.26
 Physical Scale 2.0 ± 1.9 3.1 ± 4.1 1.1 [−1.6 to 3.7] .511# 0.58
 Emotional Scale 5.0 ± 4.3 6.3 ± 6.9 1.3 [−1.9 to 4.4] .721# 0.30
 Mental Scale 3.9 ± 4.0 4.6 ± 4.9 0.8 [0.0 to 1.5] .048* 0.20
 Vigor Scale 10.7 ± 5.4 11.4 ± 5.2 0.7 [−1.8 to 3.1] .550 0.13
 Total Scale 7.0 ± 13.8 12.7 ± 24.3 5.7 [−5.5 to 16.8] .280 0.41
Abbreviations: CRT, chemoradiation treatment; CI, confidence interval; ES, effect size; EORTC QLQ-C30, European Organization for Research and 
Treatment of Cancer Quality Of Life Questionnaire-Core 30; MFSI-SF, Multidimensional Fatigue Symptom Inventory–Short Form.
*Significant (P ⩽ .05).
#Wilcoxon signed ranked test.
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that we had a 70% completion rate despite patients under-
going CRT. It is also noteworthy that the exercise sessions 
were undertaken at training facilities located away from the 
oncology treatment suite, and co-locating exercise facilities 
with the radiation and chemotherapy suites at the hospital or 
clinic may be a preferred model to enhance exercise 
participation.
In addition, we found the exercise intervention to be 
well tolerated with no adverse events related to the pro-
gram. However, one important observation was that some 
patients were possibly less tolerant of the exercise session 
in terms of pain management and bowel activation. During 
some exercise sessions, particularly after a radiation ther-
apy session, patients had to reduce the intensity of aerobic 
exercise because of irritation and activation of the bowel. 
Bowel irritation is a known effect of radiation therapy for 
both prostate27,28 and rectal cancer patients,29 although no 
patients were adversely affected such that they had to with-
draw from the entire exercise program. Nevertheless, it is 
important to note for future studies that prescribing exer-
cise prior to radiation therapy sessions may be more bene-
ficial in terms of exercise adherence and reducing bowel 
irritation. If training needs to be performed after the radia-
tion therapy session, it is essential to consider adjusting the 
exercise selection and intensity of the session accordingly.
Chemotherapy or radiation therapy and in particular 
when both treatments are combined as in the setting of CRT 
results in a range of adverse effects.26,30-32 For instance, in 
rectal cancer patients undergoing CRT, West et al26 reported 
a significant reduction in fitness levels as indicated by a 
decline in maximal oxygen consumption of almost 1.9 mL/
kg/min, while Herman et al31 reported a decline in QOL fol-
lowing CRT. Similarly, for head and neck cancer patients 
undergoing CRT, Jackson et al30 reported a reduction in LM 
of ~10%, while Samuel et al32 reported declines in func-
tional capacity and QOL in another cohort of head and neck 
cancer patients undergoing CRT.
However, as a result of the training program, lower body 
muscle strength substantially increased as did muscle 
endurance. These results are consistent with the magnitude 
of effect of exercise for cancer patients undergoing chemo-
therapy, radiation, or hormonal therapies4,5,16,33 and were 
likely induced by neural adaptations34-36 and possibly mus-
cle architecture alterations37,38 given that whole body or 
regional LM did not increase. It is important to note that 
although muscle function at post-intervention for the upper 
body did not increase, it was at least preserved following 
the 10-week period. These results indicate that exercise 
may serve as a buffer to the adverse effects of neoadjuvant 
CRT on muscle performance and help not only preserve but 
also increase a patient’s muscle function prior to surgery.
Accompanying the improvements in muscle strength 
were improvements in physical performance. These changes 
are comparable with those in a previous research trial 
undertaken in cancer patients undergoing endocrinal thera-
pies.16 Patients were physically stronger from the 10-week 
exercise program, and this likely contributed to the 
improved physical performance. Importantly, these incre-
ments in physical performance can be empowering for indi-
viduals who are close to their functional thresholds in 
performing daily living activities.30,39 For example, slow 
walking speed has been associated with reduced muscle 
strength, mobility disability, and increased mortality40; 
however, participants in our study preserved or improved 
their walking speed. This highlights the potential beneficial 
role of exercising during neoadjuvant CRT in maintaining 
functional levels during treatment and prior to surgery.41
Treatment with chemoradiation has a catabolic effect on 
skeletal muscle such that a substantial loss in LM of 6.1 kg 
was observed in head and neck cancer patients following 7 
weeks of CRT.30 A reduction in LM may result in complica-
tions especially for rectal cancer patients about to undergo 
rectal resection, with low LM associated with a longer hos-
pital stay42 and adverse clinical outcomes.43 In contrast, we 
observed that LM was largely preserved with only a reduc-
tion in ASM of 1.1 kg following training. It is highly likely 
that if patients did not undertake the exercise program while 
undergoing CRT, a substantial loss in LM would have 
occurred. Nevertheless, this loss in ASM does highlight the 
significant toxicity associated with CRT and the potential 
beneficial effects of exercise to ameliorate these declines.
The general trend for the QLQ-C30 scores shows that 
exercise did not have a significant effect on the majority of 
the various subcategories. Importantly, the majority of the 
results did not decline significantly suggesting a preserva-
tion in QOL, which perhaps could not have been expected 
during intensive CRT. This was highlighted in the work by 
Herman et al31 who reported a decline in QOL during CRT. 
Measuring QOL at 3 time points using the EORTC QLQ-
C30—before, during, and after treatment—it was shown 
that global QOL was reduced by 9.5 points during treat-
ment. A substantial decline in QOL following adjuvant 
chemoradiation has also been observed in gastric cancer 
patients.44 In contrast, in our exercise trial, patients reported 
a 3.3-point increase, although this was not statistically sig-
nificant. Nevertheless, it needs to be highlighted that our 
patients did have increased insomnia and had a higher loss 
of appetite post-exercise. These results are consistent with 
the adverse effects of chemotherapy6 and radiation therapy 
treatment.45
Our study has several limitations that are worthy of com-
ment. First, this study was not a randomized controlled trial 
but a preliminary study to determine the feasibility and pre-
liminary efficacy of a structured program being undertaken 
during CRT. Second, our patients were volunteers for this 
study trial, and as such, they are not representative of all 
rectal cancer patients undergoing neoadjuvant treatment 
prior to rectal resection. Third, our exercise intervention did 
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not significantly improve all physical assessment variables, 
possibly attributed to the variability of the adverse effects 
caused by intensive CRT, as well as small subject numbers. 
Future studies of exercise interventions for rectal cancer 
survivors undergoing CRT should consider predominantly 
resistance exercise training modalities after a radiation ther-
apy session given that we observed aerobic exercise train-
ing causes bowel irritation. Consequently, aerobic exercise 
could be scheduled for times well separated from the radia-
tion therapy session with considerations for easy access to a 
lavatory facility. Given that both exercise and diet contrib-
ute to the maintenance and accretion of LM,46 future studies 
should also examine the combined effect of nutritional 
counselling/supplementation with exercise in this patient 
population.
In conclusion, our preliminary results show initial fea-
sibility and preliminary efficacy of exercise in this new 
exercise oncology setting of neoadjuvant CRT and high-
light the need for future studies to confirm and expand our 
initial findings. Importantly, this trial indicates that in rec-
tal cancer patients, exercise helps preserve LM, muscle 
strength and physical performance, and QOL, despite 
undergoing CRT.
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